|
youth mental health |
36 |
|
mental health |
24 |
|
covid-19 |
21 |
|
depression |
21 |
|
epidemiology |
18 |
|
smartphone overuse |
14 |
|
youth |
14 |
|
adolescent |
13 |
|
adolescents |
13 |
|
stress |
13 |
|
validation study |
13 |
|
experience sampling method |
12 |
|
momentary positive affect |
12 |
|
pattern glare |
11 |
|
perceptual distortions |
11 |
|
young people |
11 |
|
community-based intervention |
10 |
|
double blind |
10 |
|
early intervention |
10 |
|
first-episode schizophrenia |
10 |
|
maintenance |
10 |
|
randomized controlled trial |
10 |
|
relapse prevention |
10 |
|
stigma |
10 |
|
youth-friendly |
10 |
|
affect |
9 |
|
autism spectrum disorder |
9 |
|
autistic disorder |
9 |
|
epidemiological youth |
9 |
|
esm |
9 |
|
loneliness |
9 |
|
momentary assessment |
9 |
|
omicron |
9 |
|
physical activity |
9 |
|
risk factors |
9 |
|
schizotypal personality disorder |
9 |
|
social context |
9 |
|
young adult |
9 |
|
controlled study |
7 |
|
depressive symptoms |
7 |
|
digitalization |
7 |
|
epidemiological study |
7 |
|
euclidean distance analysis |
7 |
|
identity |
7 |
|
multi-method approach |
7 |
|
personal attributes |
7 |
|
prevention |
7 |
|
psychiatric symptomatology |
7 |
|
real-world |
7 |
|
self |
7 |
|
self-differentiation |
7 |
|
smartphone addiction |
7 |
|
antipsychotic agents - therapeutic use |
6 |
|
child psychiatry |
6 |
|
children |
6 |
|
dibenzothiazepines - therapeutic use |
6 |
|
double-blind method |
6 |
|
family functioning |
6 |
|
hong kong |
6 |
|
humans |
6 |
|
mental health services |
6 |
|
psychotic disorders - drug therapy |
6 |
|
suicidal behaviours |
6 |
|
suicide-related rumination |
6 |
|
anxiety symptoms |
5 |
|
generalized anxiety disorder |
5 |
|
longitudinal study |
5 |
|
major depressive episode |
5 |
|
mindful attention |
5 |
|
nightmare |
5 |
|
post-traumatic stress disorder symptoms |
5 |
|
prospective study |
5 |
|
anxiety |
2 |
|
child |
2 |
|
telemedicine |
2 |
|
telepsychiatry |
2 |